title: Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection.
abstract: We report the case of an eradicated multiresistant Serratia marcescens prosthetic hip joint infection. It is estimated that enteric Gram-negative organisms account for approximately 8% of prosthetic joint infections. However, the evolving multiresistant strains of organisms being encountered in hospital acquired infections is making eradication increasingly difficult. We describe n our surgical and microbiological approach to this in a complex case.
authors.affiliation: Sheffield Teaching Hospitals NHS Foundation Trust, UK.
authors.forename: T A
authors.initials: TA
authors.lastname: Cannon
authors.forename: D G
authors.initials: DG
authors.lastname: Partridge
authors.forename: R A
authors.initials: RA
authors.lastname: Boden
authors.forename: R
authors.initials: R
authors.lastname: Townsend
authors.forename: I
authors.initials: I
authors.lastname: Stockley
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use*; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology*; D016868:Serratia Infections / Q000188:drug therapy* / Q000382:microbiology; D012706:Serratia marcescens / Q000187:drug effects* / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002939:Ciprofloxacin